United States

Curasan AG (CURG.DE)

CURG.DE on Xetra

23 Mar 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Curasan Q4 gross sales revenues up at EUR 2.11 mln
Thursday, 19 Jan 2017 03:58am EST 

Curasan AG : Gross sales revenues in Q4 rises by 37.0 percent to 2.11 million euros ($2.25 million) . Gross sales revenues at 6.94 million euros for fiscal year 2016 well within full-year forecast . For fiscal year 2017, management board of curasan ag expects sustained dynamic business performance . Anticipates gross sales revenues between 8.5 mln - 8.8 million for 2017 . Plans further increased investments in company's sales growth in order to gain larger shares of markets in asia and especially in United States .Management board therefore expects a target value between -1.6 mln and -2.2 million euros at level of net result for 2017.  Full Article

curasan successfully completes capital increase
Tuesday, 20 Dec 2016 01:29am EST 

curasan AG : Said on Monday successfully completes capital increase . Places all shares in the amount of 1,037,964 .Gross proceeds amount to around 1.00 million euros ($1.04 million).  Full Article

Curasan receives market clearance for orthopedic product in US market
Wednesday, 7 Dec 2016 02:00am EST 

Curasan AG : Receives market clearance for orthopedic product in the U.S. market . Structural reorganization of U.S. subsidiary successfully completed .FDA clearance of bone graft material CERASORB Ortho FOAM faster than expected.  Full Article

Curasan H1 gross revenues up 9.6 pct at EUR 3.35 mln
Thursday, 18 Aug 2016 02:00am EDT 

Curasan AG : Gross revenues in first half of year increase by 9.6 percent to 3.35 million euros ($3.79 million) . H1 EBITDA at -0.94 million euros was significantly below comparable figure influenced by out-of-court settlement payment to Stryker (first six months of 2015: +3.85 million euros) . Gross revenues in Q2 increase by 16.7 percent .'In next four quarters we expect significant contributions to sales from our previously announced sales offensives in United States and China," - CEO.  Full Article

Curasan accelerates expansion in the United States and China
Monday, 13 Jun 2016 04:25am EDT 

Curasan AG : Company will invest additional funds from capital increase at end of April 2016 in targeted expansion of sales and marketing activities in United States and China .American approval of CERASORB Ortho foam expected as of late 2016.  Full Article

Curasan signs marketing agreement with Silony Medical International
Tuesday, 24 May 2016 03:51am EDT 

Curasan AG : Curasan signs marketing agreement with Silony Medical International . For current fiscal year 2016, expects additional revenues of over 0.1 million euros ($111,840.00) as a result of marketing agreement . Assumes that revenues and earning contributions shall be over twice that amount starting in 2017 .In revenues and earnings forecast issued this year on April 28, this sales volume growth was already taken into consideration for 2016.  Full Article

Curasan Q1 gross revenues up 2.5 pct at 1.63 million euros
Wednesday, 11 May 2016 02:34am EDT 

Curasan AG : Q1 EBITDA decreased to -0.33 million euros ($0.38 million)from -0.07 million euros in previous year . Q1 gross revenues increased by 2.5 percent to 1.63 million euros compared to same period in 2015 .Q1 2015 final revenues of 0.13 million euros resulted from sale of remaining inventories in Q1 of 2015.  Full Article

curasan AG gives FY 2016 outlook
Thursday, 28 Apr 2016 02:11am EDT 

curasan AG:Expects gross sales between 6.7 and 7.1 million euros for 2016 fiscal year.2016 deficit for year is expected to be in range of -1.5 to -1.9 million euros in 2016.  Full Article

curasan decides on capital increase
Wednesday, 20 Apr 2016 01:45pm EDT 

curasan AG:Decides on capital increase under exclusion of subscription rights in amount of approx. 10 percent of share capital.Share capital will be increased by 943,604.00 euros ($1.07 million) to 10,379,646.00 euros.Placement price was at 1.20 euros per share.Net proceeds from capital increase of approx. 1.1 mln euros are to finance further internal and external growth of company, particularly in the US and China.  Full Article

curasan AG comments on FY 2015 outlook
Thursday, 12 Nov 2015 03:18am EST 

curasan AG:Expects FY 2015 net income range to increase from between -1.6 million and -1.2 million euros to between +1.9 million to +2.1 million euros.Anticipates sales revenues in order of 6.0 million to 6.2 million euros for year 2015, based on sales to date.  Full Article

More From Around the Web

BRIEF-Curasan Q4 gross sales revenues up at EUR 2.11 mln

* Gross sales revenues in Q4 rises by 37.0 percent to 2.11 million euros ($2.25 million)